🔴 Bio Green Med Solution is trading 7% down amid broader-market weakness; no confirmed company catalyst

Bio Green Med Solution is trading 6.85% lower at $0.86 amid broader-market weakness, though no company-specific catalyst is confirmed.

• No verified company-specific announcement explaining the October 14 decline was found; the latest company release listed was August 12.
• Provided context showed the S&P 500 down 0.67% and the Nasdaq down 0.91%.
• Reuters reported hotter-than-expected annual September CPI at 3.7%, increasing interest-rate concerns and pressuring futures. This points to macro sentiment, not a confirmed company catalyst.